These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 4640947)

  • 1. The role of iron in the pathogenesis of porphyria cutanea tarda. An in vitro model.
    Kushner JP; Lee GR; Nacht S
    J Clin Invest; 1972 Dec; 51(12):3044-51. PubMed ID: 4640947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
    Kushner JP; Steinmuller DP; Lee GR
    J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
    Alleman MA; Wilson JH; van den Berg JW; Edixhoven-Bosdijk A; van Gastel-Quist LM
    Clin Chem; 1982 May; 28(5):1144-7. PubMed ID: 7074894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of iron in experimental porphyria and porphyria cutanea tarda.
    Siersema PD; van Helvoirt RP; Cleton-Soeteman MI; de Bruijn WC; Wilson JH; van Eijk HG
    Biol Trace Elem Res; 1992 Oct; 35(1):65-72. PubMed ID: 1384628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietic porphyria of the fox squirrel Sciurus niger.
    Levin EY; Flyger V
    J Clin Invest; 1973 Jan; 52(1):96-105. PubMed ID: 4682390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
    Blekkenhorst GH; Eales L; Pimstone NR
    S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of 5-aminolevulinic acid metabolism by uroporphyrinogen I in rat liver homogenate.
    Shivji A; Bernstein M
    Clin Biochem; 1985 Apr; 18(2):88-91. PubMed ID: 4017229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyrin biosynthesis from ALA and PBG by human erythrocytes in porphyrin disorders. Kinetic studies of the isomer series I and III.
    Schermuly E; Doss M
    Ann Clin Res; 1976; 8 Suppl 17():92-102. PubMed ID: 1008503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
    Elder GH; Lee GB; Tovey JA
    N Engl J Med; 1978 Aug; 299(6):274-8. PubMed ID: 661926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias.
    Doss M; Sixel-Dietrich F; Verspohl F
    J Clin Chem Clin Biochem; 1985 Sep; 23(9):505-13. PubMed ID: 4067519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
    Mukerji SK; Pimstone NR; Burns M
    Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda.
    Felsher BF; Jones ML; Redeker AG
    JAMA; 1973 Nov; 226(6):663-5. PubMed ID: 4800611
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.
    Mukerji SK; Pimstone NR
    Arch Biochem Biophys; 1986 Feb; 244(2):619-29. PubMed ID: 3947082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activities of uroporphyrinogen synthetase and cosynthetase in congenital erythropoietic porphyria (CEP).
    Miyagi K; Petryka ZJ; Bossenmaier I; Cardinal R; Watson CJ
    Am J Hematol; 1976; 1(1):3-21. PubMed ID: 984034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Porphyria cutanea tarda in a chronic hemodialysis patient].
    Kano T; Yamane Y; Suzuki M; Yaoita H
    Nihon Hifuka Gakkai Zasshi; 1989 Jun; 99(7):819-26. PubMed ID: 2685417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
    Mukerji SK; Pimstone NR; Tan KT
    FEBS Lett; 1985 Sep; 189(2):217-20. PubMed ID: 4043380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Travelling wave ion mobility mass spectrometry of 5-aminolaevulinic acid, porphobilinogen and porphyrins.
    Benton CM; Lim CK; Moniz C; Jones DJ
    Rapid Commun Mass Spectrom; 2012 Feb; 26(4):480-6. PubMed ID: 22279024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies in porphyria. VI. Biosynthesis of porphyrins in mammalian skin and in the skin of porphyric patients.
    Bickers DR; Keogh L; Rifkind AB; Harber LC; Kappas A
    J Invest Dermatol; 1977 Jan; 68(1):5-9. PubMed ID: 830770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study.
    Siersema PD; van Helvoirt RP; Ketelaars DA; Cleton MI; de Bruijn WC; Wilson JH; van Eijk HG
    Hepatology; 1991 Dec; 14(6):1179-88. PubMed ID: 1959868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.